The title of this metabolomic study “Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” made it clear that something new was in the works. Peroxisomal dysfunction had...
Chris Armstrong PhD (biochemistry and molecular biology) was there at the beginning of the metabolomics field in chronic fatigue syndrome (ME/CFS). In fact, Armstrong was the lead author of the first ME/CFS metabolomics study published in 2012. I asked him how he got...
The overviews of the 2021 IACFS/ME Conference continue with a focus on exercise studies. “A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference “Emerging Options for Autoimmune ME/CFS”: Scheibenbogen at...
(My apologies for those who got two email blasts. I’m not sure how that happened.) In this hour plus Q&A with Sheffield ME and Fibromyalgia Group I got to blab about hot topics in fibromyalgia research, hope for future treatments, how chronic fatigue...
The muscles, the mitochondria and fibromyalgia – what a potentially potent mix. Over the past six months, at least three fibromyalgia muscle studies have popped up. (Health Rising has reviewed all three). Plus, a study examining energy production problems in...
Ron Davis’s Stanford ME/CFS Collaborative Research Center is itching to get back to full-time lab work. It’s not that Davis and his group haven’t been working. Janet Dafoe described constant Zoom calls with ME/CFS researchers, a bevy of grant...